Figure 1From: Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomasDFI in patients with TN and no-TN feline mammary carcinomas. Kaplan–Meier estimates for disease free interval probability in TN-FMCs (TN) and no TN_FMCs (no-TN) (P >0.05).Back to article page